Nick Hart discusses the importance of a forward-looking approach and how that’s guided and impacted their mission of advancing safe and affordable health care for women globally. Learn more at www.lupin.com
Mumbai, May 31, 2018: Pharma major Lupin announced the appointment of Nicholas (Nick) Hart as President – Specialty for its US business. Nick will lead the Specialty strategic business unit in the United States and will be responsible for Lupin’s Specialty brand business growth strategy, P&L and organization. A seasoned professional in the industry, Nick brings over 25 years of specialty business, strategic and commercial operations experience to Lupin. He has led the launch of numerous products both globally and in the US in multiple therapeutic areas, including Women’s Health. Most recently, Nick was the Business Unit Head for Reproductive Health at Ferring Pharmaceuticals, Inc. Prior to Ferring, he served as Senior Vice President of Sales and Marketing at URL Pharma. Nick holds a Bachelor’s of Science from The United States Military Academy at West Point and a MBA from New York University’s Stern School of Business.
Neal Howard: Welcome to Health Professional Radio, glad that you could join us. Once again, I’m your host Neal Howard. I’m going to be in conversation with Mr. Nick Hart, he’s been appointed as President of the Specialty Business at Lupin Pharmaceuticals, the fourth largest generic pharmaceutical company globally. And he’s going to discuss with us today the importance of forward-looking approach and how that’s guided and impacted their mission of advancing safe and affordable healthcare for women across the globe. Welcome to the program Nick.
Nick Hart: Good morning Neal. Thanks for the opportunity to speak with you and to your audience.
Neal: Congratulations on your recent appointment. Describe what it is that you are going to be doing there at Lupin.
Nick: Well thanks for the word of congratulations and the sentiment. Yeah, my responsibility will be as president I’m responsible for the commercial operations of Lupin US as well as the women’s health aspect of the business. And promoting our products Solosec for bacterial vaginosis and also looking for other therapies in the areas of women’s health predominantly.
Neal: Well specifically when it comes to women’s health, what are some of the challenges and opportunities that you’re looking to address for women’s healthcare?
Nick: Sure. Here at Lupin we’re interested in all aspects of women’s health, so everything from contraception to postpartum hemorrhage to hormone therapy in menopause to everything in between. So the challenges are obviously numerous. You can certainly ask any OBGYN, they’ll tell you that there are there are many challenges to each individual woman but from our perspective we’re looking for therapies that can add value to the equation in terms of meeting some unmet needs where therapies are available yet perhaps maybe not the greatest or there are just no therapies for a particular condition. We really look preferentially for those we can change the outlook for women for any particular disease. These are challenging as you might imagine because these diseases are challenging to treat or for many physicians and many women sometimes reluctant to even approach their OBGYN about some of the conditions that they face,
Neal: Now you mentioned being able to add value to women’s healthcare. With so many women’s health issues, what guides your focus in your effort to prioritize what you’re going to tackle first, second or third?
Nick: Sure. So we look at things preferentially towards the greatest unmet need for instance Solosec for the treatment of bacterial vaginosis. The treatments there were challenging because they were either administered vaginally or there are multiple pills for multiple days. We came up with that product that is one packet, one dose, one time so where there’s a condition where we feel that can change dramatically the outlook for a patient, we’ll look in that direction first. If those aren’t available, we’ll certainly look into either research or development products that can ultimately suit who have various conditions or diseases who were treated by OBGYNs.
Neal : Well you mentioned some women being reluctant to talk about some things even with their OBGYN, what do you think is the level of awareness about the importance of being upfront and do you think that that level of awareness needs to be expanded?
Nick: Sure, that’s a great question. I say that women are reluctant not because we do as you would imagine quite a bit of market research and we find that women are more comfortable typing something, as many of us, into a search on online and finding the answers so we you know we will reach out as many companies are now doing, we’ll reach out to women online and make sure that we provide as much information as we can in that vein but also challenge them or really ask them to go see their health care professional be it an OBGYN or a nurse practitioner or a physician’s assistant so that they can get that real-time diagnosis and the real treatment from a health care professional.
Neal: So once they’re with their health care professional, what is their responsibility to adequately raise awareness for his or her patient and equip them equip for the future?
Nick: Yes. I guess it might be a little bit of a dichotomy but we have also found through research that once a woman is in front of that healthcare professional, they do open up, they become much more candid, much more comfortable talking about a particular condition or a disease state. Now many physicians go through specific training in that regard to discuss with women various aspects of her health so we do find that it is beneficial to get that woman as quickly as possible into that healthcare professional.
Neal: When Lupin Pharmaceuticals is I guess sending reps out, how much education are these reps giving to the health care providers above and beyond just advising them to try your product at their practice?
Nick: Right. Well we certainly give as much information toward the patient as possible. So we naturally discuss with the healthcare professional be it a physician, a nurse practitioner or physician’s assistant – we discuss with them the ins and outs of our product based on the specific labeling that’s been approved by the FDA. But in addition to that, we want to make sure that discussion as we talked about with the healthcare professional and the patient goes as smoothly as possible and the patient is able to leave with some educational materials about their particular condition – in this case bacterial vaginosis with Solosec so we make sure that that there are plenty of materials that are easy to read, easy to understand so that the woman can leave and have a pretty good understanding, basic knowledge about a particular condition and the best way to treat it and what to look for in the future in case this condition should happen again. So we take education of the patient very seriously and we do whatever we can in terms of electronic media and printed media to get this in the hands of patients.
Neal: You mentioned many women being very comfortable as we all are with just typing in something into a search engine, where can we go online and learn more about Solosec and
Nick: Very easily, anybody can go to solosec.com or lupinpharmaceuticals.com and from either one of those sites you can dig in and find out much more information about Lupin Pharmaceuticals in the United States and elsewhere. And also about Solosec and the approved FDA labeling.
Neal: Great, thank you so much for coming in and speaking with us today Nick. It’s been a pleasure.
Nick: Thank you very much Neal, much appreciated. I enjoyed it.
Neal: You’ve been listening to Health Professional Radio, I’m your host Neal Howard. Transcripts and audio of this program are available at hpr.fm and healthprofessionalradio.com.au. You can also subscribe to the podcast on iTunes, listen in and download at SoundCloud and be sure and visit our Affiliate Page at hpr.fm